Abstract:Importance: Hidradenitis suppurativa (HS) is associated with an increased prevalence of cardiovascular diseases compared with the general population. Any association between polygenic risk for HS, risk of incident cardiometabolic outcomes, and the plasma proteome is unclear. Objective: To investigate the genetic correlation between HS and cardiometabolic disease. Design, setting, and participants: This cohort study used a polygenic risk score (PRS) for HS to examine the risks of coronary artery disease (CAD) and diabetes and identify changes in the plasma proteome in individuals of European ancestry from the UK Biobank. Participants were enrolled from January 1, 2006, to December 31, 2010. End of follow-up was January 1, 2023. Correlations were assessed between HS susceptibility and cardiometabolic traits using linkage disequilibrium score regression. Odds ratios were assessed in logistic regressions. The risk of incident CAD and diabetes was estimated in cause-specific survival models designed as time-to-event analyses. Exposure: The PRS for HS. Main outcomes and measures: Main outcomes were CAD and diabetes diagnosis measured by logistic regressions and incident disease measured by Cox proportional hazards regression models adjusted for sex, age, body mass index, and smoking status. Results: The study included 391 481 individuals (median [IQR] age, 58 [51-64] years; 209 235 [53%] female). Genetic variants for HS correlated significantly with variants associated with CAD, diabetes, and plasma levels of high-density lipoprotein cholesterol, triglycerides, and C-reactive protein. Compared with the low-risk group, a high PRS for HS (≥75th percentile) conferred odds ratios of 1.09 (95% CI, 1.06-1.12; P < .001) for CAD and 1.13 (95% CI, 1.10-1.17; P < .001) for diabetes. Estimates remained consistent when examining only incident CAD and diabetes. The PRS for HS was significantly associated with altered expression of 58 plasma proteins. Integrating this proteomic profile and the PRS for HS in a machine learning model improved prediction of CAD and diabetes compared with a reference model based on sex, age, and body mass index. Conclusions and relevance: These findings suggest that a high genetic risk of HS is associated with increased risk of subsequent CAD and diabetes and altered composition of the plasma proteome. Additional investigation into the identified proteins and their potential roles as drug targets is warranted.

Comprehensive Catalog of Variants Potentially Associated with Hidradenitis Suppurativa, Including Newly Identified Variants from a Cohort of 100 Patients

Genetic Variants Associated With Hidradenitis Suppurativa

Identification of Novel Genetic Risk Variants Associated with Hidradenitis Suppurativa in an Exome Sequencing Cohort of 92,455 Individuals

Hidradenitis Suppurativa from a Multi-Omic Scope

Hidradenitis Suppurativa: Comprehensive Review of Predisposing Genetic Mutations and Changes

Hidradenitis Suppurativa: An Understanding of Genetic Factors and Treatment

Advances in molecular pathogenesis of hidradenitis suppurativa: Dysregulated keratins and ECM signaling

Assessment of Familial Risk in Patients with Hidradenitis Suppurativa

328 Data Driven Approach Identifies Hidradenitis Suppurativa Subtypes in Electronic Health Records

Genetic Susceptibility to Hidradenitis Suppurativa and Predisposition to Cardiometabolic Disease

Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape

Haploinsufficiency Caused by a Nonsense Mutation in NCSTN Underlying Hidradenitis Suppurativa in a Chinese Family.

Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model

An Atlas of the Hidradenitis Suppurativa Transcriptome

Cytokine-Mediated Molecular Pathophysiology of Hidradenitis Suppurativa: A Narrative Review

Cellular indexing of transcriptomes and epitopes (CITE-Seq) in hidradenitis suppurativa identifies dysregulated cell types in peripheral blood and facilitates diagnosis via machine learning

The most recent advances in understanding and managing hidradenitis suppurativa

A Novel Whole Tissue Explant Model of Hidradenitis Suppurativa

Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue Specimens

A novel nicastrin mutation in a three-generation Dutch family with hidradenitis suppurativa: a search for functional significance

Epidemiology of Hidradenitis Suppurativa: Current Status